Provider Factors Likely to Impact Access and Uptake of Long-Acting Injectable Cabotegravir for Transgender Women in the United States: Results of a Qualitative Study.
Rael CT, Das D, Porter J, Lopez-Ríos J, Abascal E, Dolezal C, Vaughn MP, Giffenig P, Lopez JM, Stonbraker S, Sun C, Velasco RA, Bitterfeld L, Bockting WO, Bauermeister J.
Rael CT, et al. Among authors: lopez rios j.
J Assoc Nurses AIDS Care. 2024 Sep-Oct 01;35(5):437-449. doi: 10.1097/JNC.0000000000000488. Epub 2024 Aug 13.
J Assoc Nurses AIDS Care. 2024.
PMID: 39137316
Free PMC article.